Aida Loshaj Shala is an Assistant Professor at the Department of Pharmacy, Faculty of Medicine, University of Prishtina. She studied Pharmacy at the University of Prishtina, Kosovo, and conducted her PhD research at the Faculty of Pharmacy, University of Skopje, Northern Macedonia.

She holds a certification in Quality Control of Medicines and was a part of the team that established the Laboratory for Quality Control of Medicines at Kosovo’s Agency for Medicines and Medical Devices, building it from scratch, and served as its director.

Aida has participated in several specialized training programs and courses on the demarcation between medicinal products, medicinal devices, dietary supplements, and cosmetic products, also with BfArM. She also participated in the training program for harmonization of legislation for medicinal products for human and veterinary use organized from the European Agency of Medicines (EMA).

Aida teaches courses in Quality Control of Medicines, Basics of Pharmaceutical Technology, and Toxicology. She has published several peer-reviewed papers, contributing to her field through both research and education.

Donato Bonifazi, an economist with extensive experience in European Project Management and Clinical Research, serves as the TEDDY Network’s representative in the Coordinating Group of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), and in the Advisory Group of the Accelerating Clinical Trials in the European Union (ACT EU) Multi‑Stakeholder Platform (MSP).

Donato Bonifazi served as Chief Executive Officer of the Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF), a non-profit research consortium with more than 25 years’ experience acting as Sponsor or Partner/CRO in health and pharmaceutical studies, and acted as Trial Leader and Coordinator of the EU-funded DEferiprone Evaluation in Paediatrics (DEEP) project, involving 32 clinical centres across Europe and the Mediterranean.

Donato Bonifazi is also a member of the International Children’s Advisory Network (iCAN) Advisory Board, of the of the European Paediatric Transnational Research Infrastructure (EPTRI AISBL) Board of Directors,, of the International Rare Diseases Research Consortium (IRDiRC) Working Group on Young People Engagement, of the European CRO Federation (EUCROF) Paediatric Working Group, of the European Forum for Good Clinical Practice (EFCGP) Paediatric Medicines Working Group, and of the Italian Association of CROs (AICRO) Board of Directors. Donato Bonifazi is the Chair of the TEDDY Network Working Group on Children Engagement and Advocacy, and is actively involved in European projects aimed at advancing paediatric and rare disease research, including ERAMET, ERDERA, INVENTS, and OrphaDev4Kids, where he also act as the Coordinator.

Dr. Eleonora Passeri, PhD, is a neuroscientist by education and training, she is an expert in patient advocacy, rare diseases, science communication, and policy.  

She was the communication manager at the European Reference Network (ERN) ReCONNET, the European Joint Program on Rare Diseases (EJP RD) and the International Rare Diseases Research Consortium (IRDiRC); she was a communication consultant for the European Pediatric Translational Research Infrastructure (EPTRI) and CVBF, she also supported the patient advocacy initiatives carried on by TEDDY Network.  

In parallel, Dr. Passeri was a scientific expert for the European Union (EU) – REA program – and a Medical and Scientific Advisory Board of the Ghana Initiative for Rare Diseases as well as a healthcare professional expert at European Medicines Agency (EMA).  

Furthermore, she extended her advocacy, policy, and leadership skills by being i) the vice coordinator of Comitato Nazionale Malattie Rare (CoNaMR), National Rare Disease Committee instituted by the Italian Ministry of Health; ii) the founder of the “Rare Special Powers” (RSP) not-for-profit association focused on raising awareness of rare diseases and/or neurodevelopmental disorders; iii) a former member of the “Osservatorio sulla condizione delle persone con disabilità della Regione Umbria”. 

Moreover, Dr. Passeri is a member of the Cancer Understanding Prevention in Intellectual Disabilities (CUPID) European Cooperation in Science and Technology (COST) Action and was a former deputy leader for public awareness at COST Action Maximizing Impact of research in NeuroDevelopmental Disorders (MINDDS).  

Fiona Rako is a last year Economics student with a prospect of pursuing a master’s degree in health economics and healthcare management. She has been an active member of the KIDS Albania chapter since its beginning, by attending a lot of the summits and projects presented by TEDDY Network and its partners.
Since 2023, she is part of the TEDDY General Assembly and was also elected as its representative in the TEDDY Board of Directors.
Currently she is involved in the project proposal of “Patient-Centered Clinical Study Endpoints Derived Using Digital Health Technologies”.

Florentia Kaguelidou is a pediatrician and professor of Clinical Pharmacology at the Faculty of Medicine, Paris Cité University, Paris, France. She is the head of the Clinical Investigation Center, Inserm CIC1426 at the Robert Debré University Hospital, APHP and part of the research team URP7323, Perinatal and Pediatric Pharmacology and Therapeutic Assessment. Her research focuses on the methodology of clinical trials in pediatrics and the conduct of pediatric pharmacoepidemiology studies, with a special interest in the use and evaluation of the effects of psychotropic medications and analgesics in children.

Giorgio Reggiardo is an expert statistician with extensive experience in epidemiology, biostatistics, multivariate analysis, Bayesian inference, meta-analysis, big data analytics, and clinical trial design, including randomized controlled trials, power calculations, survival analysis, and regression methodologies. Giorgio Reggiardo is the Biostatistic Head at TEDDY as well as a member of TEDDY Board of Directors. He coordinates the TEDDY Working Group on “Paediatric Research Methodologies” with a particular focus on conducting studies and clinical research in the paediatric population. This WP supports the TEDDY’s membership in several European Union and international initiatives, such as Accelerating Clinical Trials in the European Union (ACT EU), the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), and the Standard Protocol Items for ReportIng clinical Trials (SPIRIT-children)| Consolidated Standards of Reporting Trials (CONSORT) initiatives.

Giorgio has also contributed to the CDISC (Clinical Data Interchange Standards Consortium) in Italy and collaborates with SAS Institute. He is actively involved in the leadership of the CDISC Pediatric User Network. Additionally, he has co-authored the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials).  

Founder and president of ANDO Portugal, the Skeletal Dysplasia National Association.
Member of the Committee for Orphan Medicinal Products (COMP) at the European Medicine Agency (EMA) as patient representative.
Member of Patients and consumers working party (PCWP) representing the COMP at the EMA.
Representative of the European Patient Advocacy groups (ePAG) at the European Reference Network for Rare Bone diseases (ERN BOND).
EUPATI fellow, trainer and EUPATI Portugal Vice-President.
Ph.D. candidate in Human Kinetics.
Invited assistant in the School of Health and Human Development, University of Évora.
Research member of the Comprehensive Health Research Center.
Expert evaluator of European grant call proposals in rare diseases.
Orcid ID 0000-0001-8963-4736

Madlen Gazarian is an Australian and Canadian trained Specialist Academic Physician with a unique mix of cross-disciplinary clinical and scientific expertise, experience and qualifications in Clinical Pharmacology and Therapeutics, Clinical Epidemiology and Health Services Research, Pharmacoepidemiology and Pharmacovigilance and Paediatric Medicine.
She is currently an Honorary Professor in the School of Clinical Medicine, Faculty of Medicine and Health at the University of New South Wales (UNSW) Sydney and was previously the Founding Head of the Paediatric Therapeutics Program in the School of Women’s and Children’s Health, UNSW and Sydney Children’s Hospital, Randwick, in Sydney Australia.

Professor Gazarian is a recognised national and international leader specialising in innovative, collaborative and impactful approaches to improving the development and appropriate use of medicines, with focus on the paediatric population. Her research and scholarly work focus on Evidence-Based Therapeutic decision-making, Quality Use of Medicines (Rational Use of Medicines) and Medicines Safety evaluation and improvement, including through the development and application of methodologies for optimised use and generation of Real-World Evidence (RWE).

She brings her diverse multi-sector experience, insights, and perspectives (in health service, academia, government, NGO, and industry) to provide specialised expertise and leadership in medicines and therapeutics issues to a range of Australian and international partnerships (Medicines/Therapeutics and Paediatrics networks), with significant impacts on medicines policy, therapeutics practice, education, and research at national and international levels over more than 20 years.

Key international and global roles have included the International Union of Basic and Clinical Pharmacology (IUPHAR), Paediatric sub-committee of the Clinical Pharmacology Division (2004-2010) and Founding member of the Executive committee of the Paediatric Clinical Pharmacology Section (2010-2018);

International Paediatric Association (IPA) Program Committee for Better Medicines for Children (2008-2016);

Global Research in Paediatrics (GRiP) Network of Excellence (2011-2017), Work Packages on “Joint Paediatric Clinical Pharmacology International Educational Program” (on behalf of IPA) and “Integrated Infrastructure for Paediatric Epidemiological and Postmarketing Drug Studies”;

International Society for Pharmacoepidemiology (ISPE), Special Interest and Working Groups focused on paediatrics or new methodologies in pharmacoepidemiology, including in RWE (since 2012).

Professor Gazarian joined TEDDY in 2018, with participation in various initiatives, most recently through TEDDY Working Groups on “Off-label use mitigation” and “Health data and Real-World Evidence”.

Since 2025 she represents TEDDY in the European Network of Centres in Pharmacoepidemiology and Pharmacovigilance (ENCePP) Working Group tasked with revision of ENCePP’s “Guide on Methodological Standards in Pharmacoepidemiology”.

Prof Gazarian joined the TEDDY Board in 2026.

Mariagrazia Felisi currently serves as Chief Executive Officer at Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF), where she leads the organization’s activities and ensures the highest standards in clinical research and project execution.

She is a member of the Board of Directors of TEDDY,  where she previously served as Chair and now holds the role of Past President.

She earned a Master’s Degree in Life Sciences, followed by a PhD in Clinical Pharmacology from the University of Bari in 2002 and a Master’s Degree in Pharmacovigilance from the University of Florence in 2003.

Mariagrazia has conducted extensive research in the paediatric field, with a focus on clinical pharmacology, pharmacovigilance, and the management of disease registries. Through these experiences, she has developed deep expertise in clinical research. She has been involved in numerous national and international research projects, frequently taking on leadership roles in clinical trial activities.

Prof Oscar Della Pasqua is the legal representative of TEDDY Stichting, and Chair in Clinical Pharmacology & Therapeutics at University College London, UK. He is also Senior Director of Clinical Pharmacology Modelling and Simulation at GlaxoSmithKline R&D and Associate Fellow at the National Research Council in Rome, Italy addition to his extensive experience in early and late clinical development, he leads a research group focused on biomarkers, disease modelling, and clinical trial design methodology. He has > 150 scientific publications in peer-reviewed journals and is Senior Editor of the British Journal of Clinical Pharmacology.   

Piotr Socha is graduated in Pediatrics, gastroenterology and transplantology. He works at the Children’s Memorial Health Institute (CMHI) in the Department of Gastroenterology, Hepatology, Nutritional Disorders & Pediatrics, he is Head of the Gastroenterology and Hepatology ward in CMHI since 2009 and Deputy Director for Research and Education of CMHI since 2017. He is the author and coauthor of more than 500 peer-reviewed papers.

Research and clinical work were mainly devoted to cholestatic liver disease, non-alcoholic fatty liver disease, rare metabolic liver diseases (e.g. Wilson disease, contributed to discoveries of new diseases e.g. PGM-1, V-ATPase deficiency), non-invasive markers of liver fibrosis, nutrition in hepatology and gastroenterology (e.g. LCPUFA deficiency), obesity prevention and therapy, feeding disorders, protracted diarrhea and inflammatory bowel disease of infancy and early childhood.

Dr Suja Somanadhan is Associate Professor of Children’s Nursing and Associate Dean for Global Engagement at University College Dublin. With over 25 years of experience, she advances child and youth health through equity-focused research and strategic leadership. Her work focuses on rare diseases, child health, and patient and family experiences, with the aim of improving outcomes through interdisciplinary and cross- sector collaboration. She serves as Co-Lead of the All-Ireland Rare Diseases Interdisciplinary Research Network (RAiN), Co-Chair of the Children’s Research Network Ireland and Northern Ireland, and General Assembly Member of the European Rare Disease Research Alliance (ERDERA). Through her academic and global leadership, she contributes to national and international health research strategies and capacity- building.